Management of infectious complications in percutaneous nephrolithotomy

Journal of Endourology

Volumn 23, Issue 10, 2009, Pages 1757-1762

  Negrete Pulido, Oscar ^a   Gutierrez Aceves, Jorge ^a  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; BICARBONATE; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; METRONIDAZOLE; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STEROID; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACTERIUM CULTURE; BACTERIURIA; CLINICAL EVALUATION; CLINICAL FEATURE; COMORBIDITY; DISEASE PREDISPOSITION; FEVER; FLUID RESUSCITATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION COMPLICATION; INFECTION PREVENTION; INFECTION RISK; INTENSIVE CARE; INVASIVE PROCEDURE; MICROBIAL COLONIZATION; MORBIDITY; MORTALITY; NEPHROLITHOTOMY; PATHOGENESIS; PATIENT MONITORING; PERCUTANEOUS NEPHROLITHOTOMY; PEROPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEPTICEMIA; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT INDICATION; URINALYSIS; URINARY TRACT INFECTION; URINARY TRACT OBSTRUCTION; UROLITHIASIS; UROSEPSIS;

ALGORITHMS; BACTERIAL INFECTIONS; HUMANS; INTRAOPERATIVE CARE; NEPHROSTOMY, PERCUTANEOUS; RISK FACTORS;

EID: 70350706495     PISSN: 08927790     EISSN: None     Source Type: Journal    
DOI: 10.1089/end.2009.1547     Document Type: Review

References (33)

1. Skolarikos A, Alivizatos G, de la Rosette JJ. Percutaneous nephrolithotomy and its legacy. Eur Urol 2005;47:22-28.
2. Michel MS, Trojan L, Rassweiler JJ. Complications in percutaneous nephrolithotomy. Eur Urol 2007;51:899-906.
3. Skolarikos A, de la Rosette J. Prevention and treatment of complications following percutaneous nephrolithotomy. Curr Opin Urol 2008;18:229-234.
4. O'Keeffe NK, Mortimer AJ, Sambrook PA, Rao PN. Severe sepsis following percutaneous or endoscopic procedures for urinary tract stones. Br J Urol 1993;72:277-283.
5. Rao PN, Dube DA, Weightman NC, et al. Prediction of septicemia following endourological manipulation for stones in the upper urinary tract. J Urol 1991;146:955-960.
6. Bichler KH, Elipper E, Naber K, et al. Urinary infection stones. Int J Antimicrob Agents 2002;19:488-498.
7. Neal DE Jr. Complicated urinary tract infections. Urol Clin North Am 2008;35:13-22.
8. McAleer IM, Kaplan GW, Bradley JS, et al. Endotoxin content in the renal calculi. J Urol 2003;169:1813-1814.
9. Prabakharan S, Teichman J, Spore SS, et al. Proteus mirabilis viability after lithotripsy of struvite calculi. J Urol 1999: 162;1666-1669.
10. Gómez-Núñez JG,Á lvarez UM, Fernández F, et al. Interaction of intracorporeal lithotripters with Proteus mirabilis inoculated inside artificial calcium and struvite stones. J Endourol 2009:23;519-522.
11. Gutiérrez J, Alvarez UM, Mues E, et al. Inactivation of bacteria inoculated inside urinary stones-phantoms using intracorporeal lithotripters. Urol Res 2008:36;67-72.
12. Matlaga B, Kim S, Lingeman J. Improving outcomes of percutaneous nephrolithotomy: Access. EAU Update Series 2005;3:37-43.
13. Fuchs G, Moody J, Gutiérrez-Aceves J, Barbaric Z. Complications of percutaneous renal surgery: Prevention, recognition and management. In: Taneja SS, Smith RB, Ehrlich RM, eds. Complications of Urologic Surgery: Prevention and Management. 3rd ed. Philadelphia: WB Saunders Co, 2001, pp 277-290.
14. Matlaga BR, Shah OD, Assimos DG. Complications of percutaneous approaches, including incisions. In: Nakada SY, Pearle MS, eds. Advanced Endourology: The Complete Clinical Guide. Totowa, N.Y.: Humana Press, 2006, pp 283-297.
15. Wolf JS Jr, Bennett CJ, Dmochowski RR, et al. Best practice policy statement on urologic surgery antimicrobial prophylaxis. J Urol 2008;179:1379-1390.
16. Charton M, Vallancien G, Veillon B, Brisset JM. Urinary tract infection in percutaneous surgery for renal calculi. J Urol 1986;135:15-17.
17. Darenkov AF, Derevianko II, Martov AG, et al. [The prevention of infectious-inflammatory complications in the postoperative period in percutaneous surgical interventions in patients with urolithiasis.] (Rus) Urol Nefrol (Mosk) 1994; 2:24-26.
18. Mariappan P, Smith G, Moussa SA, Tolley DA. One week of ciprofloxacin before percutaneous nephrolithotomy signifi- cantly reduces upper tract infection and urosepsis: A prospective controlled study. BJU Int 2006;98:1075-1079.
19. Mariappan P, Smith G, Bariol SV, et al. Stone and pelvic urine culture and sensitivity are better than bladder urine as predictors of urosepsis following percutaneous nephrolithotomy: A prospective clinical study. J Urol 2005;173: 1610-1614.
20. Dogan HS, Sahin A, Cetinkaya Y, et al. Antibiotic prophylaxis in percutaneous nephrolithotomy: Prospective study in 81 patients. J Endourol 2002;16:649-653.
21. Margel D, Ehrlich Y, Brown N, et al. Clinical implication of routine stone culture in percutaneous neprholithotomy-a prospective study. Urology 2006:67;26-29.
22. Dogan HS, Guliyev F, Ceinkaya YS, et al. Importance of microbiological evaluation in management of infectious complications following percutaneous nephrolithotomy. Int Urol Nephrol 2007;39:737-742.
23. Aron M, Goel R, Gupta NP, Seth A. Incidental detection of purulent fluid in kidney at percutaneous nephrolithotomy for branched renal calculi. J Endourol 2005;19:136-139.
24. Hosseini MM, Basiri A, Moghaddam SM. Percutaneous nephrolithotomy of patients with staghorn stone and incidental purulent fluid suggestive of infection. J Endourol 2007;21: 1429-1432.
25. Hinman F, Redewill FH. Pyelovenous back flow. JAMA 1926;87:1287.
26. Troxel SA, Low RK. Renal intrapelvic pressure during percutaneous nephrolithotomy and its correlation with the development of postoperative fever. J Urol 2002:168;1348-1351.
27. Zhong W, Zeng G, Wu K, et al. Does a smaller tract in percutaneous nephrolithotomy contribute to high renal pelvic pressure and postoperative fever? J Endourol 2008;22:2147-2151.
28. Gonen M, Turan H, Ozturk B, Ozkardes H. Factors affecting fever following percutaneous neprholithotomy: A prospective clinical study. J Endourol 2008;22:2135-2138.
29. Cadeddu JA, Chen R, Bishoff J, et al. Clinical significance of fever after percutaneous nephrolithotomy. Urology 1998;52: 48-50.
30. Ziaee SA, Kazemi B, Moghaddam SM, et al. A study of febrile versus afebrile patients after percutaneous nephrolithotomy regarding bacterial etiologic factors through blood and urine cultures and 16S rRNA detection in serum. J Endourol 2008;22:2717-2721.
31. Sihler KC, Nathens AB. Management of severe sepsis in the surgical patient. Surg Clin North Am 2006:86;1457-1481.
32. Nguyen B, Rivers E, Abrahamian F, et al. Severe sepsis and septic shock: Review of the literature and emergency departmentmanagement guidelines. Ann EmergMed 2006;48:28-54.
33. Gilbert DN, Moellering R, Eliopoulos GM, Sande MA, eds. The Sanford Guide to Antimicrobial Therapy, 2008. 38th ed. Sperryville, Va: Sanford Guide, 2008.